This inventor holds 5 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: University of Illinois, University of California, The University of Texas System. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
5 out of 2,437 
2 out of 16,048 
1 out of 5,644 
Years Active: 2016-2025
Title: Innovations and Contributions of Inventor Sung Hoon Kim
Introduction
Sung Hoon Kim is a notable inventor based in Champaign, IL (US). He has made significant contributions to the field of medical research, particularly in the development of compounds for the treatment of various diseases. With a total of 5 patents, his work has the potential to impact the lives of many individuals suffering from debilitating conditions.
Latest Patents
Among his latest patents is the development of estrogen receptor beta ligands for the prevention and treatment of multiple sclerosis (MS) and other demyelinating, inflammatory, and neurodegenerative diseases. The patent describes 4-Hydroxyphenyl-2H-indazol-5-ol compounds that exhibit immunomodulatory properties, enhancing oligodendrocyte survival, differentiation, and remyelination. These compounds, compositions, and kits are particularly useful in treating multiple sclerosis and endometriosis. Another significant patent involves FOXM1 inhibitor compositions and methods of use. This patent provides compounds, or pharmaceutically acceptable salts, that are effective in inhibiting FOXM1, thereby inhibiting cancer growth and treating various forms of breast cancer.
Career Highlights
Sung Hoon Kim has worked at prestigious institutions such as the University of Illinois and the University of California. His research has focused on innovative solutions to complex medical challenges, showcasing his dedication to advancing healthcare through scientific discovery.
Collaborations
Throughout his career, Kim has collaborated with esteemed colleagues, including John A. Katzenellenbogen and Benita Katzenellenbogen. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
Sung Hoon Kim's contributions to the field of medical research through his patents and collaborations highlight his commitment to innovation and improving patient outcomes. His work continues to pave the way for advancements in the treatment of serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile